beta
Trial Radar AI
Clinical Trial NCT02159742 for Neoplastic Disease is active, not recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases 400

Active, not recruiting
Clinical Trial NCT02159742 is an observational study for Neoplastic Disease that is active, not recruiting. It started on 1 July 2011 with plans to enroll 400 participants. Led by Abramson Cancer Center at Penn Medicine, it is expected to complete by 1 December 2027. The latest data from ClinicalTrials.gov was last updated on 2 July 2025.
Brief Summary
From 1996-present, we have used photodynamic therapy (PDT) to treat a number of neoplastic diseases both on prospective research protocols (for head and neck cancer, pleural malignancies, peritoneal carcinomatosis or sarcomatosis and prostate cancer) as well as for FDA approved and off label or compassionate exemption indications (neoplasms of the skin, bronchus, esophagus, head and neck and pleura). The goal of this...Show More
Official Title

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Conditions
Neoplastic Disease
Other Study IDs
  • UPCC 06911
NCT ID Number
NCT02159742
Start Date (Actual)
2011-07
Last Update Posted
2025-07-02
Completion Date (Estimated)
2027-12
Enrollment (Estimated)
400
Study Type
Observational
Status
Active, not recruiting
Keywords
Adult subjects
history
treatment
photodynamic therapy
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Cohort 1
Data Collection
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Survival and disease free
10 years
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Subjects will be age 18 or greater
  • Subjects will have undergone PDT for a diagnosis of neoplastic disease under the direction of a Penn physician.

  • None
Abramson Cancer Center at Penn Medicine logoAbramson Cancer Center at Penn Medicine130 active studies to explore
No contact data.
1 Study Locations in 1 Countries

Pennsylvania

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States